Related Experiment Videos
Epigenetic gene deregulation in cancer
1Cancer and Leukaemia in Childhood (CLIC) Research Unit, Department of Pathology and Microbiology, School of Medical Sciences, University of Bristol, University Walk, Bristol, BS8 1TD, UK. k.t.a.malik@bris.ac.uk
British Journal of Cancer
|December 6, 2000
Summary
This review covers epigenetic gene regulation in cancer. Understanding these mechanisms is key to developing new cancer therapies and improving patient outcomes.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epigenetic gene regulation plays a crucial role in normal development.
- Aberrant epigenetic modifications are hallmarks of various cancers.
- These changes can occur without altering the underlying DNA sequence.
Purpose of the Study:
- To provide a concise overview of the current literature on epigenetic gene regulation in cancer.
- To highlight key epigenetic mechanisms involved in tumorigenesis.
- To discuss the therapeutic potential of targeting epigenetic pathways.
Main Methods:
- Literature review of peer-reviewed articles.
- Synthesis of findings from studies on DNA methylation, histone modifications, and non-coding RNAs in cancer.
- Analysis of preclinical and clinical data on epigenetic drugs.
Main Results:
- DNA methylation and histone modifications are frequently altered in cancer, leading to gene silencing or activation.
- Non-coding RNAs, such as microRNAs, also contribute to epigenetic dysregulation in cancer.
- Epigenetic alterations are reversible, making them attractive therapeutic targets.
Conclusions:
- Epigenetic gene regulation is a critical factor in cancer development and progression.
- Targeting epigenetic mechanisms offers promising strategies for novel cancer therapies.
- Further research is needed to fully elucidate the complex interplay of epigenetics in different cancer types.